Anika Therapeutics, Inc. (ANIK) Net income 2016–2025
Anika Therapeutics, Inc. (ANIK) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$10.9MFY2025 · since FY2016: $32.5M → -$10.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.9M | +80.7% |
| FY2024 | -$56.4M | +31.8% |
| FY2023 | -$82.7M | -456.3% |
| FY2022 | -$14.9M | -459.4% |
| FY2021 | $4.1M | +117.2% |
| FY2020 | -$24.0M | -188.2% |
| FY2019 | $27.2M | +45.2% |
| FY2018 | $18.7M | -41.2% |
| FY2017 | $31.8M | -2.2% |
| FY2016 | $32.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice